Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Bristol Myers Squibb Co (BMY)

2014-10-30@14:54:28 ET
Bristol Myers (BMY) Trading Near $54.56 Resistance Level (FBM)

2014-10-30@14:01:43 ET
Bristol-Myers Squibb's Shares Changing Hands at Higher Prices on 3.1x Above-Average Volume (BMY) (F82)

2014-10-30@13:55:16 ET
Top 5 Performing S&P 500 Stocks (V, BMY, MA, HAR, ABC) (F70)

2014-10-30@13:00:01 ET
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement (BIZ)

2014-10-30@12:45:00 ET
Bristol-Myers Squibb/Otsuka's Abilify is a Preferred Branded Agent for the Treatment of Schizophrenia, According to Surveyed U.S. Psychiatrists and Payers (PRN)

2014-10-30@11:32:13 ET
Buyers Accumulate Shares of Bristol-Myers Squibb, Up 4.4% (F77)

2014-10-30@09:01:07 ET
Phase 2 Objective Response Rate and Survival Data for Opdivo (nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at the 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology (BIZ)

2014-10-29@15:03:10 ET
Potential Bristol Myers (BMY) Trade Has 5.20% Downside Protection (FBM)

2014-10-29@12:00:00 ET
The Market for Non-Small-Cell Lung Cancer Will Grow to $8.5 Billion in 2023, Driven by the Entry of Thirteen Novel Drugs (PRN)

2014-10-29@11:07:31 ET
M&A Navigator: Deal pipeline - 29 October (MTN)

2014-10-29@05:32:56 ET
Form 4: Update Filing for Bristol-Myers Squibb Co (BMY) (VKR)

2014-10-29@01:39:20 ET
Bristol-Myers Squibb Releases 3Q 2014 Financial Results (CLM)

2014-10-29@01:34:52 ET
Bristol-Myers Squibb Posts Third Quarter Results (CLM)

2014-10-28@12:09:41 ET
Bristol Myers (BMY) Showing Bullish Technicals (FBM)

2014-10-28@11:13:42 ET
Next Resistance Level for Bristol-Myers Squibb (BMY) is $54.45 (PSM)

2014-10-28@11:05:09 ET
M&A Navigator: Deal pipeline - 28 October (MTN)

2014-10-28@08:50:00 ET
OliPass Announces a Worldwide Discovery Alliance with Bristol-Myers Squibb for PNA-based Therapeutics (CNW)

2014-10-28@08:50:00 ET
OliPass Announces a Worldwide Discovery Alliance with Bristol-Myers Squibb for PNA-based Therapeutics (PRN)

2014-10-28@08:46:34 ET
Bristol-Myers secures option to buy UK-based F-star Alpha (MTN)

2014-10-28@07:27:56 ET
Bristol-Myers reports higher Q3 net earnings, adjusts guidance for 2014 (DTM)